Impact of Proton-pump Inhibitors on the Pharmacodynamic Effect and Clinical Outcomes in Patients Receiving Dual Antiplatelet Therapy after Percutaneous Coronary Intervention: A Propensity Score Analysis.
CONCLUSION: In this large cohort of real-world patients, the combination of PPIs with DAPT was not associated with increased risk of MACCE in patients who underwent PCI at up to 2 years of follow-up.
PMID: 29237921 [PubMed - in process]
Source: Chinese Medical Journal - Category: General Medicine Authors: Zhu P, Gao Z, Tang XF, Xu JJ, Zhang Y, Gao LJ, Chen J, Qiao SB, Yang YJ, Gao RL, Xu B, Yuan JQ Tags: Chin Med J (Engl) Source Type: research
More News: Angioplasty | Cardiology | Cardiovascular | China Health | Clopidogrel | Coronary Angioplasty | General Medicine | Heart | Heart Attack | Percutaneous Coronary Intervention | Plavix | Proton Pump Inhibitors PPIs | Stroke | Study | Thrombosis